Literature DB >> 9935184

JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alpha.

I Herr1, D Wilhelm, T Böhler, P Angel, K M Debatin.   

Abstract

We report here that stress stimuli such as gamma-irradiation or the anticancer drug doxorubicin activate expression of the death-inducing ligands (DILs) CD95-L, TNF-alpha and TRAIL. Apoptosis induced by gamma-irradiation or doxorubicin engages a FADD- and caspase-dependent apoptosis pathway which is inhibited by dominant negative FADD or the caspase inhibitor zVAD. zVAD did not prevent activity of JNK/SAPKs in response to doxorubicin suggesting that JNK/SAPK activity is independent of death receptor triggering during cellular stress-induced apoptosis. In addition, JNK/SAPKs remained activated by doxorubicin in resistant cell lines in which cleavage of caspases and apoptosis was not observed. These data uncouple JNK/SAPK activation and apoptosis signaling and indicate that cellular stress-induced apoptosis involves signaling via DILs which is paralleled by activation of JNK/SAPKs. Activation of these kinases may contribute e.g., to the expression of molecules involved in apoptosis but is not sufficient for induction of the apoptosis program following cellular stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9935184     DOI: 10.1002/(sici)1097-0215(19990129)80:3<417::aid-ijc14>3.0.co;2-b

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation.

Authors:  V K Puduvalli; D Sampath; J M Bruner; J Nangia; R Xu; A P Kyritsis
Journal:  Apoptosis       Date:  2005-01       Impact factor: 4.677

2.  c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents.

Authors:  A Kolbus; I Herr; M Schreiber; K M Debatin; E F Wagner; P Angel
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Molecular mechanisms of sulfasalazine-induced T-cell apoptosis.

Authors:  Susanne Liptay; Simone Fulda; Marta Schanbacher; Soizic Bourteele; Karine F Ferri; Guido Kroemer; Guido Adler; Klaus M Debatin; Roland M Schmid
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 4.  Shared pathways: death receptors and cytotoxic drugs in cancer therapy.

Authors:  I Peták; J A Houghton
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

5.  A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.

Authors:  S T Eichhorst; M Müller; M Li-Weber; H Schulze-Bergkamen; P Angel; P H Krammer
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases.

Authors:  C Beltinger; S Fulda; T Kammertoens; E Meyer; W Uckert; K M Debatin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 7.  Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.

Authors:  F Morceau; M Dicato; M Diederich
Journal:  Mediators Inflamm       Date:  2010-03-01       Impact factor: 4.711

8.  Remifentanil preconditioning alleviating brain damage of cerebral ischemia reperfusion rats by regulating the JNK signal pathway and TNF-α/TNFR1 signal pathway.

Authors:  Yan Zhang; Yan-Wei Li; Ya-Xin Wang; Hong-Tao Zhang; Xiao-Mei Zhang; Yu Liang; Xiu-Shan Zhang; Wen-Sheng Wang; Hai-Gen Liu; Yi Zhang; Ling Zhang; Yu-Hua Zheng
Journal:  Mol Biol Rep       Date:  2013-11-05       Impact factor: 2.316

Review 9.  Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells.

Authors:  Rachana Trivedi; Durga Prasad Mishra
Journal:  Front Oncol       Date:  2015-04-02       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.